Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Artificial intelligence can detect serious eye disease in diabetic patients

Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown that the technology can accurately detect serious eye disease among those with diabetes (retinopathy) and could halve the human workload associated with screening for diabetic eye disease, saving millions of pounds annually.

6 Jul 2020

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Without medication to manage her plaque psoriasis, Jennifer Brown's face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed.

6 Jul 2020

What seniors should know before going ahead with elective procedures

For months, Patricia Merryweather-Arges, a health care expert, has fielded questions about the coronavirus pandemic from fellow Rotary Club members in the Midwest.

6 Jul 2020

Coronavirus crisis disrupts treatment for another epidemic: Addiction

Shawn Hayes was thankful to be holed up at a city-run hotel for people with COVID-19.

6 Jul 2020

Asthma does not appear to increase the risk of COVID-19, shows study

Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.

6 Jul 2020

Cell 'membrane on a chip' could help test potential drug candidates for COVID-19

Researchers have developed a human cell 'membrane on a chip' that allows continuous monitoring of how drugs and infectious agents interact with our cells, and may soon be used to test potential drug candidates for COVID-19.

6 Jul 2020

WHO urged to recognize airborne transmission of COVID-19

Now, a team of international scientists, including 239 health experts from 32 countries, has written an open letter to the WHO urging the organization to revise its recommendations for the spread of SARS-CoV-2, due to mounting evidence that the disease is airborne for more extended periods than the WHO advisory.

6 Jul 2020

Oxford COVID-19 vaccine trials move to stage 3 human trials

The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.

5 Jul 2020

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

A new study involving over 92,000 patients with COVID-19 in Brazil shows that the odds of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent flu vaccine. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of severe COVID-19, especially among high-risk groups. The study is published on the preprint server medRxiv* in June 2020.

5 Jul 2020

High population density in India associated with spread of COVID-19

Indian health experts say the findings of a US study — which suggest that population density is unrelated to COVID-19 infection rates — to be completely contradictory to their experience of dealing with the pandemic in India, a country with 1.3 billion people.

3 Jul 2020

Study: One-third of Parkinson's patients experienced increased symptoms during lockdown

A third of people with Parkinson's have experienced increased symptoms during lockdown, according to a survey by Lancaster University and the charity Parkinson's UK.

3 Jul 2020

Survey: 6 out of 10 Swedes feel media provides the information they need on coronavirus pandemic

A decreasing proportion of Swedes think that the media's reporting on the coronavirus provides them with the information they need. Politicians who comment on the virus are perceived to be less in agreement than previously.

3 Jul 2020

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

3 Jul 2020

Official U.S.tallies likely undercount COVID-19 deaths

The United States is the hardest-hit nation amid the coronavirus pandemic, with its case toll has topping 2.73 million. The death toll in the official tally has reached 128,742. Now, a new study published in the journal JAMA Internal Medicine suggests that the coronavirus disease (COVID-19) deaths between March and May in the country were likely 28 percent higher than the official tally reported.

3 Jul 2020

Human immune response could neutralize new G virus, shows study

Flashback to mid-March: the novel coronavirus had reached San Diego, California. Few people could get tested, and even less was known about how the virus mutated as it spread from person to person.

3 Jul 2020

Study: Variation in COVID-19 viral genome improves its ability to infect human cells

Researchers have shown that a variation in the viral genome of Covid-19 improved its ability to infect human cells and helped it become the dominant strain circulating around the world today.

3 Jul 2020

Diagnosis of COVID-19 by RT-LAMP assay in 25 minutes

Even as COVID-19 continues its inexorable march, taking hundreds of thousands of lives and causing nearly 11 million cases, the diagnosis of the infection is still not sensitive or specific enough. Now, a new study by scientists at the Francis Crick Institute and published on the preprint server medRxiv...

3 Jul 2020

Mutated European strain of coronavirus more contagious but less potent

The coronavirus pandemic is far from over as it actively spreads across the globe. The infection toll has reached a staggering 10.84 million people since it emerged in late December 2019 in Wuhan City, China. The virus that has left the city has now spread to 188 countries and territories and has mutated, becoming more infectious.

3 Jul 2020

Markers of vascular damage in COVID-19

A new study by researchers at Yale University and published on the preprint server medRxiv reports on the plasma levels of biomolecules that reflect vascular damage in COVID-19.

2 Jul 2020

Effectiveness of NPI's in COVID-19 - conclusions are predictable, NPI's work

Now, a new study published on the preprint server medRxiv* looks at how the effects of these NPIs can be quantified in order to keep the public health response to COVID-19 at an adequate level. While NPIs are known to reduce the peak of the infections, in general, the researchers wanted to quantify different components separately.

2 Jul 2020